Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies

Value Health. 2011 Jun;14(4):607. doi: 10.1016/j.jval.2011.01.003.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Biomedical Technology / methods
  • Biomedical Technology / standards*
  • Cooperative Behavior*
  • Drug Industry / methods
  • Drug Industry / standards*
  • Humans
  • Technology Assessment, Biomedical / methods
  • Technology Assessment, Biomedical / standards*
  • Time Factors